STOCK TITAN

Disc Medicine to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Disc Medicine (NASDAQ:IRON) announced that company management will participate in fireside chats at three investor conferences in November 2025.

Events and times:

  • Guggenheim Second Annual Healthcare Innovation Conference — Monday, November 10, 2025 at 4:30 p.m. ET
  • Stifel 2025 Healthcare Conference — Thursday, November 13, 2025 at 8:40 a.m. ET
  • Jefferies London Healthcare Conference — Wednesday, November 19, 2025 at 2:00 p.m. GMT
Live webcasts and archived replays will be available via the company investor relations site at ir.discmedicine.com.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+0.55% News Effect

On the day this news was published, IRON gained 0.55%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WATERTOWN, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at three upcoming investor conferences:

  • Guggenheim Second Annual Healthcare Innovation Conference on Monday, November 10th at 4:30 p.m. ET.
  • Stifel 2025 Healthcare Conference on Thursday, November 13th at 8:40 a.m. ET.
  • Jefferies London Healthcare Conference on Wednesday, November 19th at 2:00 p.m. GMT.

Live webcasts of the fireside chats will be available through the investor relations section of the Company's website at ir.discmedicine.com and an archived replay will be available after each event.

About Disc Medicine

Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit www.discmedicine.com.

Media Contact

Peg Rusconi
Deerfield Group
peg.rusconi@deerfieldgroup.com

Investor Relations Contact

Christina Tartaglia
Precision AQ
christina.tartaglia@precisionaq.com


FAQ

When will Disc Medicine (NASDAQ:IRON) present at the Guggenheim Healthcare Innovation Conference?

Disc Medicine will participate in a fireside chat on Monday, November 10, 2025 at 4:30 p.m. ET.

How can investors watch Disc Medicine (NASDAQ:IRON) at the Stifel 2025 Healthcare Conference on November 13, 2025?

A live webcast will be available through Disc Medicine's investor relations site at ir.discmedicine.com, with an archived replay after the event.

What time is Disc Medicine scheduled to speak at the Jefferies London Healthcare Conference on November 19, 2025?

The fireside chat is scheduled for Wednesday, November 19, 2025 at 2:00 p.m. GMT.

Will Disc Medicine (NASDAQ:IRON) provide replay access for the November 2025 conference presentations?

Yes. Archived replays of each fireside chat will be posted on ir.discmedicine.com after each event.

Which investor conferences will Disc Medicine (NASDAQ:IRON) attend in November 2025?

Disc Medicine will participate at Guggenheim Second Annual Healthcare Innovation Conference, Stifel 2025 Healthcare Conference, and Jefferies London Healthcare Conference.

Where can investors find the schedule and webcast links for Disc Medicine (NASDAQ:IRON) November 2025 presentations?

Schedule details and webcast links will be available on the company's investor relations website at ir.discmedicine.com.
Disc Medicine Inc

NASDAQ:IRON

IRON Rankings

IRON Latest News

IRON Latest SEC Filings

IRON Stock Data

2.97B
31.55M
10.64%
101.82%
6.05%
Biotechnology
Pharmaceutical Preparations
Link
United States
WATERTOWN